Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, 53127, Bonn, Germany.
Department of Microbiology and Immunology, the Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, 3000, Australia.
Mol Biol Rep. 2024 Feb 24;51(1):342. doi: 10.1007/s11033-024-09266-2.
Myeloid cells play a vital role in innate immune responses as they recognize and phagocytose pathogens like viruses, present antigens, produce cytokines, recruit other immune cells to combat infections, and contribute to the attenuation of immune responses to restore homeostasis. Signal integration by pathogen recognition receptors enables myeloid cells to adapt their functions by a network of transcription factors and chromatin remodelers. This review provides a brief overview of the subtypes of myeloid cells and the main epigenetic regulation mechanisms. Special focus is placed on the epigenomic alterations in viral nucleic acids of HIV and SARS-CoV-2 along with the epigenetic changes in the host's myeloid cell compartment. These changes are important as they lead to immune suppression and promote the progression of the disease. Finally, we highlight some promising examples of 'epidrugs' that modulate the epigenome of immune cells and could be used as therapeutics for viral infections.
髓样细胞在先天免疫反应中起着至关重要的作用,因为它们能够识别和吞噬病毒等病原体,呈递抗原,产生细胞因子,招募其他免疫细胞来对抗感染,并有助于减轻免疫反应以恢复体内平衡。病原体识别受体的信号整合使髓样细胞能够通过转录因子和染色质重塑剂网络来适应其功能。本综述简要概述了髓样细胞的亚型和主要的表观遗传调控机制。特别关注 HIV 和 SARS-CoV-2 病毒核酸中的表观基因组改变以及宿主髓样细胞区室中的表观遗传改变。这些变化很重要,因为它们导致免疫抑制并促进疾病的进展。最后,我们强调了一些有前途的“epidrug”范例,这些范例可以调节免疫细胞的表观基因组,并可用于治疗病毒感染。
Mol Biol Rep. 2024-2-24
Eur Rev Med Pharmacol Sci. 2021-10
Biochim Biophys Acta Mol Basis Dis. 2023-3
FEMS Microbiol Rev. 2024-9-18
Diagnostics (Basel). 2024-12-15
Biomol Ther (Seoul). 2024-11-1
Front Cardiovasc Med. 2023-8-1
Nucleic Acids Res. 2023-8-25
Nat Microbiol. 2023-4
Nat Rev Immunol. 2023-9